CN115160415A - Bmor protein mutant specifically responding to n-butanol and application thereof - Google Patents

Bmor protein mutant specifically responding to n-butanol and application thereof Download PDF

Info

Publication number
CN115160415A
CN115160415A CN202110361566.7A CN202110361566A CN115160415A CN 115160415 A CN115160415 A CN 115160415A CN 202110361566 A CN202110361566 A CN 202110361566A CN 115160415 A CN115160415 A CN 115160415A
Authority
CN
China
Prior art keywords
ala
leu
arg
gly
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110361566.7A
Other languages
Chinese (zh)
Other versions
CN115160415B (en
Inventor
霍毅欣
陈振娅
毋彤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Institute of Technology BIT
Original Assignee
Beijing Institute of Technology BIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Institute of Technology BIT filed Critical Beijing Institute of Technology BIT
Priority to CN202110361566.7A priority Critical patent/CN115160415B/en
Publication of CN115160415A publication Critical patent/CN115160415A/en
Application granted granted Critical
Publication of CN115160415B publication Critical patent/CN115160415B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention belongs to the technical field of bioengineering, and particularly relates to a Bmor protein mutant specifically responding to n-butanol, and application thereof in n-butanol detection or a biosensor. The Bmor protein mutant is obtained by mutating I183T and/or D273N on the basis of wild type Bmor protein shown in a sequence table SEQ ID NO. 1. The I183T, D273N and I183T/D273N mutants are sensitive to N-butanol only and do not respond to isobutanol, so that the problem that wild Bmor protein cannot distinguish high-yield strains of N-butanol and isobutanol is solved; meanwhile, the detection range of the I183T/D273N to the N-butanol reaches 0-100mM, the response saturation of the Bmor protein to the N-butanol is improved, and the method can be used for screening and applying strains with higher yield.

Description

Bmor protein mutant specifically responding to n-butanol and application thereof
The technical field is as follows:
the invention belongs to the technical field of bioengineering, and particularly relates to a Bmor protein mutant specifically responding to n-butanol, and application thereof in n-butanol detection or a biosensor.
Background art:
the microbial synthesis of n-butanol is an important transportation fuel, and the synthesis of n-butanol through metabolic engineering is realized in a plurality of microbial hosts, and the modification of host strains and the screening of high-yield hosts are the basis and key for realizing the industrial production of alcohol. Biosensors can specifically respond to a target compound to output a protein signal that is convenient to detect, and thus have been widely used for high-throughput screening.
The biosensor consists of a molecular recognition element and a signal converter. When the molecular recognition element is combined with the object to be measured, the generated signal can be converted into an optical signal or an electrical signal by the converter, and the object to be measured can be detected and analyzed. As an emerging tool in synthetic biology, biosensors can be designed and constructed to dynamically respond to changes in signal molecule concentration. Meanwhile, biosensors are designed to facilitate the optimization of microbial cell factories and the production of a range of natural products widely used in industry, such as itaconic acid, fatty acids, isobutanol, n-butanol and alkaloids. The biosensor mainly comprises an RNA nucleic acid switch, a transcription factor regulated biosensor, a G protein coupled receptor and a fluorescent protein biosensor. The development of the biosensor in the biological world is hindered by the disadvantages that the low dynamic range of the fluorescent protein biosensor, the difficulty of performing RNA nucleic acid switch in vitro and the capability of performing G protein coupled receptor only in the extracellular space are overcome.
Transcription Factor (TF) -based biosensors are most widely used. The most commonly used transcription factors are bacterial transcription factors, including the Ligand Binding Domain (LBD) or the Metabolic Binding Domain (MBD) and the DNA Binding Domain (DBD). Bmor is a transcription factor of the Pseudomonas normal paraffin metabolic pathway, is a member of bEBP, and is used for regulating sigma of alkane monooxygenase 54 Dependent promoter P bmo The signal molecule is a C2-C5 linear or branched alcohol. However, the wild-type transcription factor Bmor has poor response specificity, can respond to both substrates of n-butyl alcohol and isobutyl alcohol and cannot respond to one substrate of the n-butyl alcohol and the isobutyl alcoholThe seed alcohol performs specific response, thereby meeting the industrial requirement; and the detection range is narrow (0-40 mM), and the like, and the method cannot be widely applied to biosensors. Therefore, the realization of specific response to alcohol and the improvement of detection range become problems to be solved urgently.
The Bmor protein mutant obtained by modifying the protein can realize the specific response to n-butanol, improves the upper limit of substrate detection and response strength, and provides a solution for efficiently detecting n-butanol and quickly screening high-yield strains.
The invention content is as follows:
the invention aims to provide a Bmor protein capable of distinguishing normal butanol from isobutanol, a biosensor and application. And (3) constructing a random mutation library by using an error-prone PCR (polymerase chain reaction) technology, and screening and analyzing the mutation library by adding n-butyl alcohol and isobutanol from an external source to finally obtain the Bmor mutant protein only responding to the n-butyl alcohol.
Further, the BmoR mutant protein only responding to N-butanol is obtained by carrying out I183T and/or D273N mutation on the basis of the wild-type BmoR protein shown in SEQ ID No.1 of the sequence table, and is hereinafter referred to as I183T mutant, D273N mutant and I183T/D273N mutant (simultaneously carrying out I183T and D273N mutations), and the mutant protein is specifically:
(1) An amino acid sequence shown in SEQ ID NO.3, 5 or 7 of the sequence Listing; or
(2) An amino acid sequence having more than 75% homology with SEQ ID No.3, 5 or 7; or
(3) Amino acid sequences with the same functions as SEQ ID No.3, 5 or 7 obtained after one or more amino acid substitutions, and/or deletions, and/or additions are carried out on the basis of SEQ ID No.3, 5 or 7.
Further, the present invention also provides genes encoding the I183T mutant, the D273N mutant, and the I183T/D273N mutant;
furthermore, the coding gene is shown in a sequence table SEQ ID NO.4, 6 or 8.
It is another object of the present invention to provide the use of the I183T mutant, the D273N mutant or the I183T/D273N mutant, particularly in the detection of a sample containing N-butanol or in the screening of N-butanol producing strains, more particularly in the construction of a biosensor for the detection of N-butanol;
further, the biosensor is based on an I183T mutant, a D273N mutant or an I183T/D273N mutant, and the sensor comprises a gene encoding the I183T mutant, the D273N mutant or the I183T/D273N mutant and a promoter thereof, namely a promoter P bmo And an expression element of a reporter gene; the promoter starts the expression of the bmoR gene, the BmoR protein is combined with an alcohol molecule to form a hexamer, and then the downstream promoter P is started bmo Thereby expressing the reporter gene and generating signals such as fluorescence; the biosensor can realize specific response and screening of n-butanol under the concentration of 0-100mM, and is further applied to industrial production to realize specific screening of a sample containing n-butanol and a n-butanol production strain;
further, the promoter of the gene encoding the mutant includes, but is not limited to, P bmoR 、P tac 、P T7 、 P LlacO1 Etc.;
further, the reporter gene includes, but is not limited to, gfp, rfp, cfp, sfgfp, egfp, yfp, ecfp and other genes;
preferably, the biosensor is a gene encoding I183T mutant, D273N mutant or I183T/D273N mutant and its promoter P bmoR Promoter P bmo And a gfp reporter gene; further, expression vectors that may be used for the recombinant plasmid include, but are not limited to, those commonly used in the art, such as pET, pUC19, pMAL, and the like;
more preferably, the biosensor is obtained by replacing the wild-type Bmor protein-encoding gene on plasmid pYH1 with the gene encoding the I183T mutant, D273N mutant or I183T/D273N mutant, i.e., will be derived from P bmoR The promoter I183T mutant, D273N mutant or I183T/D273N mutant encodes a gene linked to the colE1 replication initiation site, amp r And P bmo Driven gfp gene;
further, the n-butanol producing strains include, but are not limited to, escherichia coli, saccharomyces cerevisiae, bacillus subtilis, and the like;
further, the promoter P bmoR The nucleotide sequence of (A) is shown as a sequence table SEQ ID NO. 9;
further, the promoter P bmo The nucleotide sequence of (A) is shown in a sequence table SEQ ID NO. 10;
furthermore, the nucleotide sequence of the gfp reporter gene is shown in a sequence table SEQ ID NO. 11.
The invention also provides the application of the biosensor in n-butanol detection, in particular to the application in the environment, food, medical and biological samples containing n-butanol or the screening of n-butanol producing strains, and the plasmid is introduced into producing strains, such as escherichia coli, saccharomyces cerevisiae, bacillus subtilis and the like, or introduced into a separate host (such as escherichia coli XL10-Gold and the like) and then added into a detection system to detect the production of n-butanol.
Has the advantages that:
1. the biosensor based on the Bmor can be used for screening strains with high yield of N-butanol or isobutanol, but wild Bmor has response to both N-butanol and isobutanol, cannot be distinguished, and has poor specificity.
2. The detection range of the wild Bmor is too narrow, the detection range of the wild Bmor is 0-40mM for the n-butanol, and the response is saturated when the substrate concentration reaches 40mM, so that the wild Bmor cannot be used for identifying the strain with the n-butanol yield higher than 40 mM. The I183T/D273N mutant provided by the invention has a detection range of 0-100mM for N-butanol, improves the response saturation of Bmor protein for N-butanol, and can be used for screening and applying N-butanol high-level production strains.
Description of the drawings:
FIG. 1 is a schematic flow chart;
firstly, carrying out random mutation on the first 1000bp of the N end of wild type bmoR through error-prone PCR to obtain a random mutation library of the BmoR; GFP fluorescent protein is added at the downstream of the bmoR gene, and the response condition of the mutant BmoR to the n-butanol can be reflected by detecting the fluorescence intensity. The response of the mutant BmoR to the alcohol molecule was examined by adding n-butanol at different concentrations.
FIG. 2 shows the response of Bmor mutant and wild type to 10mM n-butanol and isobutanol;
FIG. 3 shows the response of Bmor mutant and wild type to 0-100mM n-butanol and isobutanol;
FIG. 4 shows the molecular docking of the I183T/D273N mutant with N-butanol and isobutanol.
The specific implementation mode is as follows:
the invention is described below by means of specific embodiments. Unless otherwise specified, the technical means used in the present invention are well known to those skilled in the art. In addition, the embodiments should be considered illustrative, and not restrictive, of the scope of the invention, which is defined solely by the claims. It will be apparent to those skilled in the art that various changes or modifications in the components and amounts of the materials used in these embodiments can be made without departing from the spirit and scope of the invention.
The biosensor provided by the invention is based on an I183T mutant, a D273N mutant or an I183T/D273N mutant, and the sensor comprises an I183T mutant, a D273N mutant or an I183T/D273N mutant encoding gene and a promoter thereof, and a promoter P bmo And an expression element of a reporter gene; the promoter starts the expression of the bmoR gene, the BmoR protein is combined with an alcohol molecule to form a hexamer, and then the downstream promoter P is started bmo Thereby expressing the reporter gene and generating signals such as fluorescence. The person skilled in the art can select promoters to drive the expression of the Bmor mutant gene in the prior art according to the actual situation, for example, by using P bmoR 、P tac 、P T7 、P LlacO1 And the like. The reporter gene can be selected from various choices, and protein molecules which are commonly used in the field and can generate visual detection signals or small molecular substances for detection, such as fluorescent protein, chromoprotein and the like, can realize the response of the biosensor,preferably, such as gfp, rfp, cfp, sfgfp, egfp, yfp, ecfp, etc. The sensor also comprises the necessary elements for realizing expression, such as a replication initiation site, preferably, a colE1 replication initiation site and the like. The sensor may also comprise a marker such as a resistance gene, e.g., amp r And the like, so that the screening is convenient. The skilled person can also add other elements to the sensor according to actual needs, for example, construct the elements on expression vectors in the prior art, such as pET, pUC19, pMAL, etc., to obtain recombinant plasmids that can be used as sensors.
Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
The invention will be further explained below by means of specific examples.
Example 1 screening of Bmor mutants I183T, D273N and I183T/D273N
Construction of random mutation library of transcription factor Bmor
(1) The mutant gene of the wild type Bmor (shown in SEQ ID NO. 2) is obtained by taking a plasmid pYH1 (see DOI: https:// doi.org/10.1016/j.ymben.2019.08.015; https:// doi.org/10.1186/s 12934-019-1084-2) as a template and performing error-prone PCR amplification (by adding Mn into a PCR system 2+ Increasing Mg in PCR System 2+ Concentration and adjustment of dNTP ratio to introduce random mutations. A10 Xunbalanced dNTPs mixture was prepared in which the concentration of dCTP, dTTP was four times that of dATP, dGTP. The PCR program was set up as follows: pre-denaturation at 94 ℃ for 2min,30 amplification cycles comprising: denaturation at 95 ℃ for 1min, annealing at 55-68 ℃ for 1min, and determining the appropriate extension time at 72 ℃ according to the amplification rate of 1kb per minute. The storage temperature was set at 16 ℃. ) (ii) a Confirming the PCR product by gel electrophoresis, and recovering and purifying; the purified product was placed in a 37 ℃ water bath and digested with DpnI (1. Mu.L/50. Mu.L purified product) for 1-2h. mu.L of the bmoR mutant fragment (with the bmoR wild-type fragment as a control), 3. Mu.L of pYH1 backbone (alternatively constructed with P) bmoR (or other promoters), P bmo Plasmid of gfp fluorescent protein gene (or other reporter gene) as a backbone, equivalent to pYH1 backbone) and 5mu.L of Gibson Assembly Mix, mixed and placed in a 50 ℃ water bath for ligation for 1h. Transferring 5-10 μ L of the ligation product into 50 μ L of Escherichia coli XL 10-Gold-transformed competent cells, and culturing overnight at 37 ℃ to obtain a Bmor-1000bp mutation library.
(2) Single colonies on the plate were picked, inoculated into 5mL of LB (100. Mu.g/mL Amp) liquid medium, and cultured at 37 ℃ and 220rpm for 8 hours as a seed solution. Primary screening was performed using 96-deep well plates. 950 μ L of fresh LB (100 μ g/mL Amp) medium was added to each well; respectively adding n-butanol or isobutanol into the pores to make the final concentration of the mixture to be 10mM; finally, 50. Mu.L of seed solution was pipetted into each well. After sealing the sealing film, the deep-well plate was placed in a shaker at 30 ℃ and 220rpm for 16h.
(3) Fluorescence intensity GFP and OD Using microplate 600 And (3) detection: blowing and beating the mixed bacteria liquid, sucking 200 mu L of the mixed bacteria liquid, putting the mixed bacteria liquid into an enzyme-labeling instrument, and quantitatively detecting the mixed bacteria liquid at 30 ℃ with the set parameters as follows: an excitation wavelength of 470nm, an emission wavelength of 510nm, and a gain value of 50; the obtained GFP and OD 600 Values the background control values were first subtracted and the GFP/OD was calculated for each well based thereon 600 As a relative fluorescence intensity value.
(4) After analyzing the preliminary screening results, the plasmids of the effective mutant bacteria were sequenced.
Determining mutants which only respond to the n-butanol, specifically: an I183T mutant (the amino acid sequence is shown as SEQ ID NO.3 in a sequence table, and the nucleotide sequence is shown as SEQ ID NO. 4) with the 183 th amino acid mutated from Ile to Thr, a D273N mutant (the amino acid sequence is shown as SEQ ID NO.5 in the sequence table, and the nucleotide sequence is shown as SEQ ID NO. 6) with the 273 th amino acid mutated from Asp to Asn, an I183T/D273N mutant (the amino acid sequence is shown as SEQ ID NO.7 in the sequence table, and the nucleotide sequence is shown as SEQ ID NO. 8) with the 183 th amino acid mutated from Ile to Thr and the 273 nd amino acid mutated from Asp to Asn, GFP/OD of the mutants, and the like 600 The preliminary screening results are shown in table 1 below and fig. 2, and it can be seen that the I183T, D273N and I183T/D273N mutants respond only to N-butanol, relative to wild-type BmoR.
TABLE 1 GFP/OD 600
Bmor protein N-butanol Isobutanol
WT 983 868
I183T/D273N 54.0 0.00
I183T 39.9 0.00
D273N 25.0 0.00
Example 2 concentration gradient assay to determine the Change in detection Limit for wild type and mutant
The wild Bmor-based biosensor can realize the response to 0-40mM n-butyl alcohol or isobutyl alcohol and has response to both n-butyl alcohol and isobutyl alcohol; when the substrate concentration is higher than 40mM, the response value tends to be saturated, and the response cannot be carried out on alcohol molecules with higher concentration. The specific response of the Bmor biosensor based on the 1183T/D273N mutant to 0-100mM N-butanol/isobutanol was verified experimentally below.
Respectively carrying out concentration gradient N-butanol on strains containing I183T/D273N mutant genes and wild Bmor genes on the basis of primary screening resultsOr exogenous addition experiment of isobutanol, measuring response curve and calculating K m Response intensity value, etc.
The single colonies on the plate were picked, inoculated into 5mL of LB (100. Mu.g/mLAmp) liquid medium, and cultured at 37 ℃ and 220rpm for 8 hours as a seed solution.
Exogenous addition experiments were performed in sterilized 2mL 96 deep well plates. 950. Mu.L of fresh LB (100. Mu.g/mL Amp) medium was added to each well, then n-butanol or isobutanol were added to the medium to give final concentrations of 0, 1, 10, 20, 40, 60, 80, 100mM, respectively, and finally 50. Mu.L of seed solution was inoculated to each well, and after sealing the sealing film, the deep well plate was incubated at 30 ℃ for 16h on a shaker at 220 rpm.
Fluorescence intensity GFP and OD Using microplate 600 And (3) detection: blowing and beating the mixed bacteria liquid, sucking 200 mu L of the mixed bacteria liquid, putting the mixed bacteria liquid into an enzyme-labeling instrument, and quantitatively detecting the mixed bacteria liquid at 30 ℃ with the set parameters as follows: 470nm excitation wavelength and 510nm emission wavelength, gain value is 50; the obtained GFP and OD 600 Values the background control values were first subtracted from the values, and the GFP/OD of each well was calculated based thereon 600 As a relative fluorescence intensity value.
At GFP/OD 600 Using the final concentrations of the n-butanol and the isobutanol as the ordinate and the final concentrations of the n-butanol and the isobutanol as the abscissa respectively, using originPro 8.5 or GraphPad Prism 8 software for mapping, carrying out Mie's fitting on the data, and calculating the K of the Bmor mutant for the n-butanol and the isobutanol according to the fitting result m Maximum response strength, etc. (fig. 3).
Screening a random mutation library at the concentration of 10mM substrate to obtain a mutant I183T/D273N which specifically responds to N-butanol and does not respond to isobutanol; further verification is carried out under the condition of 0-100mM gradient concentration, and the result shows that the mutant still keeps specific response to the n-butanol and hardly responds to the isobutanol under the condition of different n-butanol and isobutanol concentrations. Mapping by originPro 8.5 wild type Bmor at substrate concentrations 0-100mM, K for n-butanol m 3.78K for isobutanol m Is 4.24; the I183T/D273N mutant has K in N-butanol at a substrate concentration of 0-100mM m 15.7K for isobutanol m Is 33.2;K m As characterization of the affinity, K m The larger the value, the smaller the affinity; k is m The smaller the value, the greater the affinity.
The wild type Bmor can respond to 0-40mM of n-butanol or isobutanol, and when the concentration is higher than 40mM, the response is saturated, so that the wild type Bmor cannot distinguish the n-butanol or the isobutanol of more than 40 mM; the calculation result shows that the mutant has K compared with the wild type m The value is obviously improved, and the Bmor mutant can realize the specific response (0-100 mM) of n-butanol with higher concentration; meanwhile, N-butanol K of I183T/D273N mutant m Value less than isobutanol K m Values further indicating that the mutant has a greater affinity for n-butanol than for isobutanol. In agreement with the experimental results.
Example 3 model analysis
Sequencing the I183T/D273N mutant, analyzing the change of amino acid at the mutation site, modeling the Bmor mutant by using software such as AUTODOCK, chimeraX and the like, butting the mutant with small molecular substrates such as N-butanol and isobutanol respectively, and analyzing the formation of the binding site and hydrogen bond of the mutant and the two alcohols.
The three-dimensional structure of the wild Bmor protein is used as a template to carry out homologous modeling on the I183T/D273N mutant, and the homology rate is 99.6%. And further carrying out molecular docking on the mutant structure and a substrate molecule (n-butyl alcohol or isobutyl alcohol). The results show that the mutant has 2 hydrogen bond interactions (Leu 260, arg 211) with n-butanol in the complex, and does not form any interaction force with isobutanol, indicating that n-butanol can tightly bind to the mutant and K m The results of the numerical analysis remained consistent, i.e., specifically responded to n-butanol (FIG. 4).
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is specific and detailed, but not to be understood as limiting the scope of the patent. It should be noted that, for those skilled in the art, various changes, combinations and improvements can be made in the above embodiments without departing from the patent concept, and all of them belong to the protection scope of the patent. Therefore, the protection scope of this patent shall be subject to the claims.
SEQUENCE LISTING
<110> Beijing university of science and technology
<120> Bmor protein mutant specifically responding to n-butanol and application thereof
<130> 1
<160> 11
<170> PatentIn version 3.5
<210> 1
<211> 669
<212> PRT
<213> Pseudomonas bacteria (Pseudomonas butanovora)
<400> 1
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Ile Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asp Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 2
<211> 2010
<212> DNA
<213> Pseudomonas bacteria (Pseudomonas butanovora)
<400> 2
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacatct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcgacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 3
<211> 669
<212> PRT
<213> Artificial sequence
<400> 3
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Thr Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asp Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 4
<211> 2010
<212> DNA
<213> Artificial sequence
<400> 4
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacacct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcgacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 5
<211> 669
<212> PRT
<213> Artificial sequence
<400> 5
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Ile Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asn Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 6
<211> 2010
<212> DNA
<213> Artificial sequence
<400> 6
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacatct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcaacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 7
<211> 669
<212> PRT
<213> Artificial sequence
<400> 7
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Thr Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asn Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 8
<211> 2010
<212> DNA
<213> Artificial sequence
<400> 8
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacacct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcaacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 9
<211> 138
<212> DNA
<213> Pseudomonas (Pseudomonas butanovora)
<400> 9
gaccttgagg tgaccttgag cgggcagata ccaccaaaat ttcccacgtg ctattatggt 60
tttgctaaag ctctcgacag cgaggagaga ctcgcgaaga taagcaattc gcccgacaga 120
ggtgaatgag gagacggt 138
<210> 10
<211> 524
<212> DNA
<213> Pseudomonas (Pseudomonas butanovora)
<400> 10
ccccccaacg acgtccgtca gagcccggtt cgagtggctt ctatatgccg atcatcggtg 60
gctctattgt ggcggtcagt gacaccggtc gccttcaccc ccacagatag taggtgctgc 120
ggctgctcat gctcctgtcg cggtagcgcg ctgttacgcg accgcccccg gacctcggcg 180
gacagcgcgg aagattggaa acagcccgag cgtgcgtgcc tcgggctgca tccttgccac 240
acccaaccgg attcgtcgga ccgctcgaca ttcgcgttcg ctcccgcggc gccgcgggtg 300
taccgttgcg ttacagatgt acccttcttt aacgtgtaac acacgcctgg agcggccaag 360
agccccgcac cttgcggcgc gtcttcccca ggggcccacc ggttgcggcc ttttgctgcg 420
accgtccatg ctggcacgac acttgctgaa agcgttagag cggaatcggt ccgatggagc 480
attcgaagcc gctaccgaca gcagaacaca caaaggagga agtg 524
<210> 11
<211> 717
<212> DNA
<213> Artificial sequence
<400> 11
atgcgtaaag gagaagaact tttcactgga gttgtcccaa ttcttgttga attagatggt 60
gatgttaatg ggcacaaatt ttctgtcagt ggagagggtg aaggtgatgc aacatacgga 120
aaacttaccc ttaaatttat ttgcactact ggaaaactac ctgttccatg gccaacactt 180
gtcactactt tcggttatgg tgttcaatgc tttgcgagat acccagatca tatgaaacag 240
catgactttt tcaagagtgc catgcccgaa ggttatgtac aggaaagaac tatatttttc 300
aaagatgacg ggaactacaa gacacgtgct gaagtcaagt ttgaaggtga tacccttgtt 360
aatagaatcg agttaaaagg tattgatttt aaagaagatg gaaacattct tggacacaaa 420
ttggaataca actataactc acacaatgta tacatcatgg cagacaaaca aaagaatgga 480
atcaaagtta acttcaaaat tagacacaac attgaagatg gaagcgttca actagcagac 540
cattatcaac aaaatactcc aattggcgat ggccctgtcc ttttaccaga caaccattac 600
ctgtccacac aatctgccct ttcgaaagat cccaacgaaa agagagacca catggtcctt 660
cttgagtttg taacagctgc tgggattaca catggcatgg atgaactata caaataa 717

Claims (13)

1. A Bmor mutant protein is characterized in that the mutant is obtained by carrying out mutation containing I183T and/or D273N on the basis of a wild Bmor protein shown in a sequence table SEQ ID NO. 1.
2. The Bmor mutant protein according to claim 1, wherein the mutant protein is in particular:
(1) An amino acid sequence shown in SEQ ID NO.3, 5 or 7 of the sequence Listing; or
(2) An amino acid sequence having more than 75% homology with SEQ ID No.3, 5 or 7; or
(3) Amino acid sequences with the same functions as SEQ ID No.3, 5 or 7 obtained after one or more amino acid substitutions, and/or deletions, and/or additions are carried out on the basis of SEQ ID No.3, 5 or 7.
3. Use of a BmoR mutant according to claim 1 for detecting a sample containing n-butanol, or for screening n-butanol producing strains.
4. Use of the BmoR mutant of claim 1 to construct a biosensor for detecting n-butanol.
5. The gene encoding the Bmor mutant of claim 1.
6. The coding gene of claim 5, which is represented by SEQ ID No.4, 6 or 8 of the sequence Listing.
7. A recombinant plasmid or a recombinant strain comprising the encoding gene of claim 5.
8. A biosensor comprising a promoter P activated by a Bmor mutant and comprising a gene encoding the mutant of claim 5 bmo From P bmo A driven reporter gene and an expression element for expressing a promoter for the BmoR mutant.
9. The biosensor of claim 8, wherein the reporter genes include, but are not limited to, gfp, rfp, cfp, sfgfp, egfp, yfp, ecfp genes.
10. The biosensor of claim 8, wherein the promoter for expression of the Bmor mutant includes, but is not limited to, P bmoR 、P tac 、P T7 、P LlacO1
11. The biosensor of claim 8, wherein the sensor is to be represented by P bmoR The initiated mutant-encoding gene is linked to the colE1 replication initiation site, amp r And P bmo The gfp gene was initiated.
12. Biosensor according to claim 8, wherein the promoter P is bmo The nucleotide sequence of (A) is shown in a sequence table SEQ ID NO. 10.
13. Use of the biosensor of claim 8 for detecting n-butanol-containing environmental, food, medical, biological samples, and screening n-butanol-producing strains.
CN202110361566.7A 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof Active CN115160415B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110361566.7A CN115160415B (en) 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110361566.7A CN115160415B (en) 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof

Publications (2)

Publication Number Publication Date
CN115160415A true CN115160415A (en) 2022-10-11
CN115160415B CN115160415B (en) 2024-02-09

Family

ID=83476148

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110361566.7A Active CN115160415B (en) 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof

Country Status (1)

Country Link
CN (1) CN115160415B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065105A1 (en) * 2009-04-24 2011-03-17 The Regents Of The University Of California Novel transcription factor-based biosensor
CN110615832A (en) * 2019-09-27 2019-12-27 北京理工大学 Bmor mutant for efficiently screening isobutanol high-yield strains
CN110885777A (en) * 2019-08-19 2020-03-17 山东汇冠康博生物科技有限公司 Method for screening isobutanol high-yield strain by using Bmor biosensor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065105A1 (en) * 2009-04-24 2011-03-17 The Regents Of The University Of California Novel transcription factor-based biosensor
CN110885777A (en) * 2019-08-19 2020-03-17 山东汇冠康博生物科技有限公司 Method for screening isobutanol high-yield strain by using Bmor biosensor
CN110615832A (en) * 2019-09-27 2019-12-27 北京理工大学 Bmor mutant for efficiently screening isobutanol high-yield strains

Also Published As

Publication number Publication date
CN115160415B (en) 2024-02-09

Similar Documents

Publication Publication Date Title
AU1520099A (en) Methods and compositions for peptide libraries displayed on light-emitting scaffolds
CN113073089B (en) Novel method for improving enzyme activity of NMN biosynthetic enzyme Nampt
CN113061591B (en) Novel firefly luciferase mutant, preparation method and application thereof
CN104781419A (en) Sensor for nadp (h) and development of alcohol dehydrogenases
CN116113643A (en) Synthetic expression system
KR20210084590A (en) engineered DNA polymerase variants
US6737245B1 (en) Luciferase expression cassettes and methods of use
CN115160415B (en) BmoR protein mutant specifically responding to n-butanol and application thereof
CN112280877A (en) CRISPR-Cas13a system for detecting coxiella burnetii nucleic acid
WO2018138201A1 (en) Promoter construct for cell-free protein synthesis
CN115181168B (en) BmoR protein mutant insensitive to ethanol and specifically responsive to n-butanol
US7067282B2 (en) Compositions and methods using the yeast YLR110C promoter
CN115991746A (en) Bmor mutant specifically responding to isobutanol and application thereof
CN115991748A (en) BmoR mutant-based high-sensitivity biosensor
CN115991747A (en) BmoR mutant-based high-sensitivity biosensor
CN116023447A (en) BmoR mutant-based wide-area biosensor
CN112375771B (en) Homoserine biosensor and construction method and application thereof
CN115181167B (en) Screening method of ethanol production strain based on BmoR mutant
JP6824594B2 (en) How to design synthetic genes
CN112831482B (en) Method for rapidly detecting PRPP and biosensor used by same
CN106749560B (en) Discovery and application of lipid droplets or fat bodies through transcriptional regulation participated by MLDSR protein
Bashmakova et al. Development of the method to produce functionally active recombinant streptavidin in escherichia coli cells
KR101550217B1 (en) Recombinant vector for foreign gene expression without biological circuit interference of host cell and uses thereof
WO2023123509A1 (en) Mutant and uses thereof
CN118222537A (en) Taq DNA polymerase mutant with improved performance and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant